ADWPF yields 4.58% · JNJ yields 2.14%● Live data
📍 ADWPF pulled ahead of the other in Year 1
Combined, ADWPF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ADWPF + JNJ for your $10,000?
Andrew Peller Limited engages in the production, bottling, and marketing of wines and craft beverage alcohol products in Canada. The company offers products under Peller Estates, Trius, Thirty Bench, Wayne Gretzky, Sandhill, Red Rooster, Black Hills Estate Winery, Tinhorn Creek Vineyards, Gray Monk Estate Winery, Raven Conspiracy, and Conviction brands; Peller Family Vineyards, Copper Moon, Black Cellar, and XOXO brands; and Hochtaler, Domaine D'Or, Schloss Laderheim, Royal, and Sommet brands. It also produces craft beverage alcohol products, including No Boats on Sunday ciders and seltzers, beer, spirits, and cream whisky products under the Wayne Gretzky No. 99 brand. In addition, the company produces and markets personal winemaking products under Winexpert, Vine Co., Apres, LE, Passport Series, On the House, Wild Grapes, DIY My Wine Co., Island Mist, and Niagara Mist brands; and distributes these products through authorized and independent retailers in Canada, as well as through additional distributors in the United States, the United Kingdom, New Zealand, Australia, and China. Further, it owns and operates 101 independent retail locations in Ontario under The Wine Shop, Wine Country Vintners, and Wine Country Merchants store names; and operates Andrew Peller Import Agency, importers, marketing agents, and The Small Winemaker's Collection Inc. to import premium wines from around the world. The company was formerly known as Andrés Wines Ltd. and changed its name to Andrew Peller Limited in 2006. Andrew Peller Limited was founded in 1961 and is headquartered in Grimsby, Canada.
Full ADWPF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.